279 related articles for article (PubMed ID: 18474583)
1. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
Jeannot K; Elsen S; Köhler T; Attree I; van Delden C; Plésiat P
Antimicrob Agents Chemother; 2008 Jul; 52(7):2455-62. PubMed ID: 18474583
[TBL] [Abstract][Full Text] [Related]
2. Real-Time Monitoring of
Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa.
Purssell A; Poole K
Microbiology (Reading); 2013 Oct; 159(Pt 10):2058-2073. PubMed ID: 23924707
[TBL] [Abstract][Full Text] [Related]
4. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
Dean CR; Visalli MA; Projan SJ; Sum PE; Bradford PA
Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
[TBL] [Abstract][Full Text] [Related]
5. Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators.
Morero NR; Monti MR; Argaraña CE
Antimicrob Agents Chemother; 2011 Aug; 55(8):3668-76. PubMed ID: 21646492
[TBL] [Abstract][Full Text] [Related]
6. EsrC, an envelope stress-regulated repressor of the mexCD-oprJ multidrug efflux operon in Pseudomonas aeruginosa.
Purssell A; Fruci M; Mikalauskas A; Gilmour C; Poole K
Environ Microbiol; 2015 Jan; 17(1):186-98. PubMed ID: 25143244
[TBL] [Abstract][Full Text] [Related]
7. Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump.
Morita Y; Komori Y; Mima T; Kuroda T; Mizushima T; Tsuchiya T
FEMS Microbiol Lett; 2001 Aug; 202(1):139-43. PubMed ID: 11506922
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa.
Poole K; Gotoh N; Tsujimoto H; Zhao Q; Wada A; Yamasaki T; Neshat S; Yamagishi J; Li XZ; Nishino T
Mol Microbiol; 1996 Aug; 21(4):713-24. PubMed ID: 8878035
[TBL] [Abstract][Full Text] [Related]
10. Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa.
Stickland HG; Davenport PW; Lilley KS; Griffin JL; Welch M
J Proteome Res; 2010 Jun; 9(6):2957-67. PubMed ID: 20373734
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms decreasing in vitro susceptibility to the LpxC inhibitor CHIR-090 in the gram-negative pathogen Pseudomonas aeruginosa.
Caughlan RE; Jones AK; Delucia AM; Woods AL; Xie L; Ma B; Barnes SW; Walker JR; Sprague ER; Yang X; Dean CR
Antimicrob Agents Chemother; 2012 Jan; 56(1):17-27. PubMed ID: 22024823
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
Mulet X; Maciá MD; Mena A; Juan C; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2009 Apr; 53(4):1552-60. PubMed ID: 19188376
[TBL] [Abstract][Full Text] [Related]
13. Functional replacement of OprJ by OprM in the MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa.
Gotoh N; Tsujimoto H; Nomura A; Okamoto K; Tsuda M; Nishino T
FEMS Microbiol Lett; 1998 Aug; 165(1):21-7. PubMed ID: 9711836
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.
Mulet X; Moyá B; Juan C; Macià MD; Pérez JL; Blázquez J; Oliver A
Antimicrob Agents Chemother; 2011 Oct; 55(10):4560-8. PubMed ID: 21807976
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes.
Peng J; Cao J; Ng FM; Hill J
J Proteomics; 2017 Jan; 152():75-87. PubMed ID: 27771372
[TBL] [Abstract][Full Text] [Related]
16. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.
Chuanchuen R; Beinlich K; Hoang TT; Becher A; Karkhoff-Schweizer RR; Schweizer HP
Antimicrob Agents Chemother; 2001 Feb; 45(2):428-32. PubMed ID: 11158736
[TBL] [Abstract][Full Text] [Related]
17. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.
Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
Antimicrob Agents Chemother; 2000 Dec; 44(12):3322-7. PubMed ID: 11083635
[TBL] [Abstract][Full Text] [Related]
18. Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression.
Caughlan RE; Sriram S; Daigle DM; Woods AL; Buco J; Peterson RL; Dzink-Fox J; Walker S; Dean CR
Antimicrob Agents Chemother; 2009 Dec; 53(12):5015-21. PubMed ID: 19786597
[TBL] [Abstract][Full Text] [Related]
19. Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin.
Llanes C; Köhler T; Patry I; Dehecq B; van Delden C; Plésiat P
Antimicrob Agents Chemother; 2011 Dec; 55(12):5676-84. PubMed ID: 21911574
[TBL] [Abstract][Full Text] [Related]
20. nfxB as a novel target for analysis of mutation spectra in Pseudomonas aeruginosa.
Monti MR; Morero NR; Miguel V; Argaraña CE
PLoS One; 2013; 8(6):e66236. PubMed ID: 23762483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
